Companies: 10,795·Total market cap: $144.5T
Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc.

BOLTNASDAQHealthcare● Active
$4.72
+$0.16(+3.51%)
Market Cap$9069796
P/E Ratio—
52W High$7.35
52W Low$3.91
EmployeesOwnershipInsider Trades

Bolt Biotherapeutics, Inc. (BOLT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BOLT · as of Mar 12, 2026

Latest filing snapshot

50
-2-3.85%vs prior year

Bolt Biotherapeutics, Inc. (BOLT) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
50
Change (1Y)
-2
Growth % (1Y)
-3.85%
Revenue / Employee
$153.9K
Net Income / Employee
$-667.5K
Market Cap
$9M

BOLT Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1250-2-3.85%
2025-03-2452-48-48.00%
2024-03-21100+6+6.38%
2023-03-2994+3+3.30%
2022-03-3091+26+40.00%
2021-03-3165——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Evogene Ltd.
EVGN
Evogene Ltd.
117#2
Bolt Biotherapeutics, Inc.
BOLT
Bolt Biotherapeutics, Inc.YOU
50#3
Imunon, Inc.
IMNN
Imunon, Inc.
25#4
IN8bio, Inc.
INAB
IN8bio, Inc.
18#5
Cingulate Inc.
CING
Cingulate Inc.
13#6
Cellectar Biosciences, Inc.
CLRB
Cellectar Biosciences, Inc.
11
#7
AEON Biopharma, Inc.
AEON
AEON Biopharma, Inc.
5
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BOLT peer comparison

About BOLT employees

BOLT Employees · Headcount

Bolt Biotherapeutics, Inc. (BOLT) employee data is sourced from the annual SEC 10-K filing. As of 2025, Bolt Biotherapeutics, Inc. had 50 full-time employees globally. Full-time employees only. Global consolidated headcount.

Bolt Biotherapeutics, Inc. employs 50 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $153,900, reflecting the company's operational efficiency.

Bolt Biotherapeutics, Inc.'s workforce decreased by 2 (3.85%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Bolt Biotherapeutics, Inc.'s revenue per employee of $153,900 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

BOLT Employees · 5 questions

As of the latest SEC 10-K filing (2025), Bolt Biotherapeutics, Inc. had 50 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Bolt Biotherapeutics, Inc. employee counthow many employees does Bolt Biotherapeutics, Inc. haveBOLT total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12